Dainippon Sumitomo Applies For Higher Daily Dosage For Meropen
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo May 31 submitted an application to change the maximum daily dosage for ultra-broad injectable antibiotic Meropen (meropenem) from 2g to 3g